首页|期刊导航|中华医学杂志(英文版)|Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trial
Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trial
Jun-Bo Ge Ying-Wu Liu Sheng-Huang Wang Sheng-Hu He Ping Yang Jie Wu Feng Lu Zi-Shan Hou Wei-Hu Fan Jing-Min Zhou Hai-Ming Shi Fu-Sui Ji Yang Wu Yu-Lan Zhao Jun Qian Yuan-Zhe Jin
中华医学杂志(英文版)2021,Vol.134Issue(2):185-192,8.
中华医学杂志(英文版)2021,Vol.134Issue(2):185-192,8.DOI:10.1097/CM9.0000000000001257
Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trial
Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trial
摘要
关键词
MUSKARDIA/Stable coronary artery disease/Angina/Major adverse cardiovascular eventKey words
MUSKARDIA/Stable coronary artery disease/Angina/Major adverse cardiovascular event引用本文复制引用
Jun-Bo Ge,Ying-Wu Liu,Sheng-Huang Wang,Sheng-Hu He,Ping Yang,Jie Wu,Feng Lu,Zi-Shan Hou,Wei-Hu Fan,Jing-Min Zhou,Hai-Ming Shi,Fu-Sui Ji,Yang Wu,Yu-Lan Zhao,Jun Qian,Yuan-Zhe Jin..Efficacy and safety of Shexiang Baoxin pill(MUSKARDIA)in patients with stable coronary artery disease:a multicenter,double-blind,placebo-controlled phase Ⅳ randomized clinical trial[J].中华医学杂志(英文版),2021,134(2):185-192,8.基金项目
This study was funded by the Shanghai Science and Technology Committee and Shanghai Hutchison Pharmaceuticals Company. ()